Science journalism by Leonid Schneider, on research integrity and academic publishing in life sciences and biomedicine
Katrin Amunts is director of Human Brain Project. Back when the Berlin Wall fell, this Moscow-trained young neuroscientist from GDR found a new mentor in Western Germany: Professor Karl Zilles. It is a remarkable story of a literal brain drain.
Two old gynaecology professors in Milan decided to racially profile, then rate their misinformed young patients for sexual attractiveness. Their even published this as an evo-psych study in a respected society journal.
Oncotarget, the somewhat controversial OA journal, switched from pretend-soliciting my services to threatening to sue me for defamation. Their lawyer writes my disrespect caused them financial damage.
The emails published here prove that EU Special Envoy for OA, Robert Jan Smits, received constant counselling from Frontiers CEO Kamila Markram when designing Plan S. It seems, Frontiers and Smits share exactly same vision for the future of scholarly publishing.
If you thought you already saw the worst research fraud from China, here comes the next level. Anything goes to please the Communist Party and to advance own academic career under the oppressive regime.
Lynn Kamerlin, Bas de Bruin and their colleagues have been the most vocal critics of Plan S from the very beginning, braving continuous opposition from certain OA leaders. Now that final Plan S guidelines were released, the chemists publish this Open Letter expressing their worry about a possible dystopian OA future.
In this guest post by Smut Clyde and Tiger BB8 you will witness a publication practice you would never have thought possible. Even from China. Even at Elsevier.
A former Karolinska researcher is subject of research misconduct investigation, for forwarding to university OA publishing bills for her past research there. To save €3k, no trick is too dirty for Karolinska Institutet.
Royal Society of Chemistry published a research paper which unashamedly peddled TCM, under the title: “Probing the Qi of traditional Chinese herbal medicines by the biological synthesis of nano-Au”. Both Editor-in-Chief and publisher executive saw no problem there because the paper passed peer review.
A cancer research professor in China runs a paper mill, sources claim he sells first authorships for a bribe. Problem for his customers: the peer-reviewed papers they pay for, contain fake data.
